Domov › Ploščatocelični karcinom glave in vratu › Connecticut › New Haven
Klinične študije za Ploščatocelični karcinom glave in vratu v New Haven, CT
22 študij za Ploščatocelični karcinom glave in vratu išče udeležence na lokacijah v New Haven in okolici (v razdalji približno 30 milj). Odprite študijo, da vidite, kdo lahko sodeluje in kako kontaktirati ekipo.
Uradno besedilo študije (angleško)
Iščete udeležence za študijo? Predstavite jo na vrhu te strani — $99 za 30 dni →
Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
Vključevanje udeležencevFaza 1
- Exelixis Clinical Site #62, New Haven
A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors
Vključevanje udeležencevFaza 1
- Smilow Cancer Hospital - Yale New Haven Health, New Haven
- Yale - New Haven Hospital - Yale Cancer Center, New Haven
- Smilow Cancer Hospital Phase 1 Unit, New Haven
Anti-Ly6E Exatecan ADC M7437 in Advanced Solid Tumors
Vključevanje udeležencevFaza 1
- Yale University - Yale University School of Medicine, New Haven
A Study of Amivantamab in Addition to Standard of Care Agents (SOC) Compared With SOC Alone in Participants With Recurrent/Metastatic Head and Neck Cancer
Vključevanje udeležencevFaza 3
- Yale Cancer Center, New Haven
A Study of Amivantamab Alone or in Addition to Other Treatment Agents in Participants With Head and Neck Cancer
Vključevanje udeležencevFaza 1/2
- Yale Cancer Center, New Haven
Testing What Happens When an Immunotherapy Drug (Pembrolizumab) is Given by Itself Compared to the Usual Treatment of Chemotherapy With Radiation After Surgery for Recurrent Head and Neck Squamous Cell Carcinoma
Vključevanje udeležencevFaza 2
- Smilow Cancer Center/Yale-New Haven Hospital, New Haven
- Yale University, New Haven
Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
Vključevanje udeležencevFaza 1
- Yale University, Yale Cancer Center, New Haven
Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery
Vključevanje udeležencevFaza 2
- Smilow Cancer Center/Yale-New Haven Hospital, New Haven
- Yale University, New Haven
- Yale-New Haven Hospital North Haven Medical Center, North Haven · 7 mi stran
- in še 1
First in Human Study of TUB-030 in Patients With Advanced Solid Tumors
Vključevanje udeležencevFaza 1/2
- Yale Cancer Center, New Haven
ADCE-T02, a Tissue Factor Targeted Antibody-Drug Conjugate, in Patients With Selected Advanced Solid Tumours
Vključevanje udeležencevFaza 1
- Yale University Cancer Center, New Haven
A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors
Vključevanje udeležencevFaza 1
- Normunity Investigational Site, New Haven
Comparing Sentinel Lymph Node (SLN) Biopsy With Standard Neck Dissection for Patients With Early-Stage Oral Cavity Cancer
Vključevanje udeležencevFaza 2/3
- Yale University, New Haven
CUE-101with Pembrolizumab for Locally Advanced HPV+HNSCCs
Vključevanje udeležencevFaza 2Vabljeni zdravi prostovoljci
- Yale University, New Haven
A Study to Investigate ALE.P02 as Monotherapy in Adult Patients With Selected CLDN1+ Solid Tumors
Vključevanje udeležencevFaza 1/2
- Yale Comprehensive Cancer Center, New Haven
Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors
Vključevanje udeležencevFaza 1/2
- Yale University, Yale Cancer Center, New Haven
5-Azacytidine and/or Nivolumab in Resectable HPV-Associated HNSCC
Vključevanje udeležencevFaza 2
- Yale University, New Haven
Study With ABBV-CLS-484 in Participants With Locally Advanced or Metastatic Tumors
Vključevanje udeležencevFaza 1
- Yale University School of Medicine /ID# 225707, New Haven
A Study of Dostarlimab vs Placebo After Chemoradiation in Adult Participants With Locally Advanced Unresected Head and Neck Squamous Cell Carcinoma
Vključevanje udeležencevFaza 3
- GSK Investigational Site, New Haven
A Study of Ficlatuzumab in Combination With Cetuximab in Participants With Recurrent or Metastatic (R/M) HPV Negative Head and Neck Squamous Cell Carcinoma
Vključevanje udeležencevFaza 3
- Yale School of Medicine - Smilow Cancer Hospital, New Haven
A Phase I/II Study of VLS-1488 in Subjects With Advanced Cancer
Vključevanje udeležencevFaza 1/2
- Yale Cancer Center, New Haven
Phase 1a and Phase 2 Study for Safety, Preliminary Efficacy, PK and PD of ST-067
Vključevanje udeležencevFaza 1/2
- Yale Cancer Center, New Haven
Phase II Trial of Neoadjuvant and Adjuvant IO102-IO103 and Pembrolizumab KEYTRUDA® in Patients With Resectable Tumors
Vključevanje udeležencevFaza 2
- Yale, New Haven
Študije za Ploščatocelični karcinom glave in vratu v drugih mestih
- Houston, TX47 študij
- Los Angeles, CA42 študij
- Boston, MA40 študij
- New York City, NY39 študij
- Nashville, TN39 študij
- St. Louis, MO28 študij
- Arlington, VA26 študij
- Philadelphia, PA26 študij
- Chicago, IL26 študij
- Atlanta, GA24 študij
- San Antonio, TX22 študij
- Pittsburgh, PA22 študij
Druge študije v New Haven
- Nemalicelični pljučni rak41 študij
- Rak dojke38 študij
- Rak (vse vrste)33 študij
- Metastatski rak23 študij
- Rak pljuč22 študij
- Rak jajčnikov21 študij
- Kolorektalni rak20 študij
- Rak prostate20 študij
- Akutna mieločna levkemija17 študij
- Motnja uporabe alkohola (AUD)17 študij
- Prevelik odmerek opioidov17 študij
- Rak trebušne slinavke16 študij
Vir: ClinicalTrials.gov, podatki pridobljeni 6. okt. 2026. Vsaka študija ima svoje pogoje vključitve; ekipa študije odloči, kdo lahko sodeluje.